SwitchGear Providing Roche's FuGene HD Reagent | GenomeWeb

This article has been corrected to note that Fugent is the owner of the FuGene technology, not Roche as previously reported.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SwitchGear Genomics today announced it will distribute Fugent's FuGene HD transfection reagent.

The product will be offered by Switchgear as a standalone product, as well as part of the company's LightSwitch Transfection Optimization kit.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.